JPMorgan Chase & Co’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,915
Closed -$708 6799
2025
Q1
$708 Sell
1,915
-8
-0.4% -$3 ﹤0.01% 5790
2024
Q4
$1.37K Buy
1,923
+90
+5% +$64 ﹤0.01% 5635
2024
Q3
$2.05K Hold
1,833
﹤0.01% 5552
2024
Q2
$2K Hold
1,833
﹤0.01% 5508
2024
Q1
$2.33K Hold
1,833
﹤0.01% 5545
2023
Q4
$2.55K Hold
1,833
﹤0.01% 5647
2023
Q3
$2.57K Hold
1,833
﹤0.01% 5552
2023
Q2
$3.37K Hold
1,833
﹤0.01% 5348
2023
Q1
$4K Buy
1,833
+1,763
+2,519% +$3.85K ﹤0.01% 5448
2022
Q4
$0 Hold
70
﹤0.01% 5999
2022
Q3
$0 Hold
70
﹤0.01% 5881
2022
Q2
$0 Hold
70
﹤0.01% 5960
2022
Q1
$0 Hold
70
﹤0.01% 5990
2021
Q4
$0 Hold
70
﹤0.01% 5958
2021
Q3
$0 Sell
70
-107,650
-100% ﹤0.01% 5802
2021
Q2
$341K Sell
107,720
-31,552
-23% -$99.9K ﹤0.01% 4218
2021
Q1
$478K Buy
139,272
+7,057
+5% +$24.2K ﹤0.01% 4072
2020
Q4
$334K Buy
132,215
+111,227
+530% +$281K ﹤0.01% 3957
2020
Q3
$43K Buy
20,988
+6,047
+40% +$12.4K ﹤0.01% 4331
2020
Q2
$33K Sell
14,941
-50,352
-77% -$111K ﹤0.01% 4330
2020
Q1
$166K Buy
65,293
+39,331
+151% +$100K ﹤0.01% 3774
2019
Q4
$68K Buy
25,962
+9,325
+56% +$24.4K ﹤0.01% 4144
2019
Q3
$60K Buy
16,637
+4,516
+37% +$16.3K ﹤0.01% 4184
2019
Q2
$43K Buy
12,121
+1,377
+13% +$4.89K ﹤0.01% 4318
2019
Q1
$29K Sell
10,744
-13,448
-56% -$36.3K ﹤0.01% 4407
2018
Q4
$67K Sell
24,192
-40,885
-63% -$113K ﹤0.01% 4175
2018
Q3
$268K Buy
65,077
+16,386
+34% +$67.5K ﹤0.01% 3763
2018
Q2
$252K Sell
48,691
-117,273
-71% -$607K ﹤0.01% 3735
2018
Q1
$910K Buy
165,964
+157,079
+1,768% +$861K ﹤0.01% 3129
2017
Q4
$72K Sell
8,885
-15,792
-64% -$128K ﹤0.01% 4018
2017
Q3
$263K Buy
+24,677
New +$263K ﹤0.01% 3379
2017
Q2
Sell
-26,241
Closed -$220K 4549
2017
Q1
$220K Buy
+26,241
New +$220K ﹤0.01% 3454
2016
Q2
Sell
-45,167
Closed -$206K 4373
2016
Q1
$206K Buy
+45,167
New +$206K ﹤0.01% 3147
2013
Q4
Sell
-21,476
Closed -$54K 3789
2013
Q3
$54K Sell
21,476
-300
-1% -$754 ﹤0.01% 3813
2013
Q2
$45K Buy
+21,776
New +$45K ﹤0.01% 3781